Literature DB >> 9566669

An immunocytochemical study of the distribution of proline-4-hydroxylase in normal, osteoarthritic and rheumatoid arthritic synovium at both the light and electron microscopic level.

S C Smith1, V A Folefac, D K Osei, P A Revell.   

Abstract

The monoclonal antibody 5B5 reacts with the beta subunit of proline-4-hydroxylase, the enzyme which catalyses the formation of 4-hydroxyl proline in collagen and other proteins with collagen-like amino acid sequences. This study aims to assess the production and tissue distribution of this enzyme in normal and diseased synovia from patients with various joint diseases, on the basis that it is a putative marker of collagen-producing cells and, therefore, in this context, of fibroblasts. Sections from five normal, 10 osteoarthritic (OA) and 26 rheumatoid arthritic (RA) synovia were labelled with a mouse monoclonal antibody to proline-4-hydroxylase. The enzyme was found to be expressed by a proportion of synovial intimal cells and by fibroblasts in the underlying connective tissue in normal, OA and RA synovia. Labelling was more pronounced in OA and RA cases. The intimal cells labelling positively showed type B synoviocyte morphology, which was confirmed by subsequent double immunolabelling with 5B5 and antibody against type IV collagen using immunocytochemistry and immunoelectron microscopy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566669     DOI: 10.1093/rheumatology/37.3.287

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  2 in total

1.  The fluence effects of low-level laser therapy on inflammation, fibroblast-like synoviocytes, and synovial apoptosis in rats with adjuvant-induced arthritis.

Authors:  Yueh-Ling Hsieh; Yu-Jung Cheng; Fang-Chuen Huang; Chen-Chia Yang
Journal:  Photomed Laser Surg       Date:  2014-12       Impact factor: 2.796

2.  Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.

Authors:  E Kunisch; R Fuhrmann; A Roth; R Winter; W Lungershausen; R W Kinne
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.